The Latest Breaking News on Pharma

China's ultra-strict COVID-19 curbs are taking a toll on businesses and jobseekers as Beijing stresses again and again the need to maintain its zero-tolerance approach to the virus, to save lives, if not livelihoods.

Several months after the US government began investigating an Abbott Laboratories baby-formula plant for its connection to the deaths of at least two infants, the world’s most influential judge of corporate environmental, social and governance practices upgraded the company.

The medicines regulator is considering whether to put some restrictions on how paracetamol is sold because of concerns about its use in self-harm.

"This study is too flawed to be used to set policy on the mRNA vaccines in younger males," one expert said

Pfizer Inc. and its German vaccine partner said their booster tailored to the latest omicron variants raised more antibodies against the dominant strains of COVID-19 when compared with the original shot designed to fight the form of the virus.

Pfizer and its German partner BioNTech said their COVID-19 vaccine booster, adapted for the BA.4 and the BA.5 subvariants of Omicron, generated a strong immune response and was well-tolerated in testing on humans. With the results, which the companies described as consistent with preclinical data, the partners are following up…

In an attempt to clamp down on recreational drug use, the British government recently set out a three-tier system for dealing with people caught in possession of illegal substances.

Employees were informed of the phased cuts earlier today

Uptake of this version of the booster will likely remain low for kids, unless there's a wintertime surge of new cases.